Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Miho Watanabe Nemoto"'
Autor:
Akiyo Takada, Hajime Yokota, Miho Watanabe Nemoto, Takuro Horikoshi, Koji Matsumoto, Yuji Habu, Hirokazu Usui, Katsuhiro Nasu, Makio Shozu, Takashi Uno
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282710 (2023)
ObjectivesWe investigated prospectively whether, in cervical cancer (CC) treated with concurrent chemoradiotherapy (CCRT), the Apparent diffusion coefficient (ADC) histogram and texture parameters and their change rates during treatment could predict
Externí odkaz:
https://doaj.org/article/179eaaafa134440abcbad90367c013a6
Autor:
Miho Watanabe Nemoto, Hiroki Kobayashi, Yuma Iwai, Takashi Uno, A. Kanazawa, Marie Kurokawa, Takuro Horikoshi, Makoto Saito, Rintaro Harada
Publikováno v:
Japanese Journal of Radiology. 38:899-905
The Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG) published recommendations for contouring high-risk clinical target volumes (HR-CTV) on CT for 3-dimentional image-guided brachytherapy for c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3e4c26dea9d8e5b088d73a0a5589289
https://doi.org/10.1007/s11604-020-00980-y
https://doi.org/10.1007/s11604-020-00980-y
Autor:
Hajime Yokota, Miho Watanabe Nemoto, Akiyo Takada, Takuro Horikoshi, Jun Matsushima, Takashi Uno
Publikováno v:
Japanese Journal of Radiology. 38:265-273
This study aimed to identify the most appropriate volume of interest (VOI) setting in prognostic prediction using pretreatment magnetic resonance imaging (MRI) radiomic analysis for cervical cancer (CC) treated with definitive radiotherapy. The study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b3870638f7fef5fbf9689ff244aed05
https://doi.org/10.1007/s11604-019-00917-0
https://doi.org/10.1007/s11604-019-00917-0
Autor:
Marie Kurokawa, Miho Watanabe Nemoto, R. Harada, Takashi Uno, G. Togasaki, Yuma Iwai, Hiroki Kobayashi
Publikováno v:
Japanese Journal of Radiology. 35:760-765
We propose a method of image-guided brachytherapy (IGBT) that combines MRI-based target volume delineation for the first fraction with CT datasets of subsequent fractions, using an automatic, applicator-based co-registration, and report our prelimina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f754ddb13a69d1ba2fcd537279a66d26
https://doi.org/10.1007/s11604-017-0690-3
https://doi.org/10.1007/s11604-017-0690-3
Radiation Therapy for Extrapelvic Lymph Node Recurrence After Curative Treatment for Cervical Cancer
Autor:
A. Kanazawa, Takashi Uno, Akira Mitsuhashi, Makoto Saito, Rintaro Harada, Hiroki Kobayashi, Miho Watanabe Nemoto, Yuma Iwai, Makio Shozu, Hirokazu Usui
Publikováno v:
Anticancer research. 39(2)
Background/aim To investigate outcomes of patients with cervical cancer who received radiation therapy for extrapelvic lymph node recurrence after initial pelvic radiotherapy. Patients and methods The treatment charts of 20 patients were retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115b74d53b51fc745237cb192d42fa94
https://pubmed.ncbi.nlm.nih.gov/30711972
https://pubmed.ncbi.nlm.nih.gov/30711972
Autor:
Miho Watanabe Nemoto, A. Kanazawa, Shiroh Isono, G. Togasaki, Marie Kurokawa, Takashi Uno, Hiroki Kobayashi, R. Harada, Natsuko Nozaki-Taguchi
Publikováno v:
Brachytherapy. 14:642-647
Background and Purpose To relieve the pain and distress experienced by women who undergo high-dose-rate intracavitary radiotherapy (HDR-ICRT) for cervical cancer and to improve the current status of gynecologic brachytherapy in Japan, a new intraveno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e47c83d7c95e7d7d0ece428cf56bbd
https://doi.org/10.1016/j.brachy.2015.04.009
https://doi.org/10.1016/j.brachy.2015.04.009
Autor:
Takuro Horikoshi, Yoshitaka Okamoto, Takashi Uno, Rintaro Harada, A. Kanazawa, Miho Watanabe Nemoto, Yukinao Abe, Marie Kurokawa, Hiroki Kobayashi, G. Togasaki, Hideaki Chazono, Toyoyuki Hanazawa
Publikováno v:
Journal of Radiation Research
In Japan, cetuximab with concurrent bioradiotherapy (BRT) for squamous cell carcinoma of head and neck (SCCHN) was approved in December 2012. We herein report our initial experience of BRT, with special emphasis on acute toxicities of this combinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7bd5356dce24d5e9d26c52cef4f815
http://europepmc.org/articles/PMC4577007
http://europepmc.org/articles/PMC4577007
Autor:
Makio Shozu, Miho Watanabe-Nemoto, Takashi Uno, Hirokazu Usui, Kyoko Nishikimi, Akira Mitsuhashi, Shin-ichi Tate, Takashi Uehara, Noriko Yamamoto, Shinsuke Hanawa
Publikováno v:
International Journal of Gynecological Cancer. 25:891-896
Objectives It has been established that concurrent chemoradiotherapy (CCRT) is efficacious for cervical cancer, but adherence is unsatisfactory among elderly patients. To improve adherence, we have developed and initiated a daily low-dose cisplatin-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb7dbea8148b9d397de89c28654e8694
https://doi.org/10.1097/igc.0000000000000436
https://doi.org/10.1097/igc.0000000000000436
Autor:
A. Kanazawa, Hiroyuki Kobayashi, G. Togasaki, Makoto Saito, Marie Kurokawa, Miho Watanabe Nemoto, Takashi Uno, Koichi Isobe, Hisao Ito, Rintaro Harada
Publikováno v:
Journal of Radiation Research
The purpose of this study was to retrospectively evaluate the incidence of delayed renal dysfunction after total body irradiation (TBI) in long-term survivors of TBI/hematopoietic stem cell transplantation (HSCT). Between 1989 and 2006, 24 pediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b6d34e64d68afa2889ee357fc68ba8
https://doi.org/10.1093/jrr/rru041
https://doi.org/10.1093/jrr/rru041
Autor:
Shinichi Tate, Akira Mitsuhashi, Hirokazu Usui, Kyoko Nishikimi, Makio Shozu, Shinsuke Hanawa, Noriko Yamamoto, Miho Watanabe-Nemoto, Takashi Uno
Publikováno v:
American journal of clinical oncology. 40(2)
The prevention of chemotherapy-induced and radiotherapy-induced emesis is recommended by several guidelines; however, there are no evidence-based recommendations for the use of antiemetics in concurrent chemoradiotherapy (CCRT). The aim of the presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050b9bd9743ea1f88bc6cf5a6c8489f4
https://pubmed.ncbi.nlm.nih.gov/25144265
https://pubmed.ncbi.nlm.nih.gov/25144265